These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 27936517
1. Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis. Koutsonikoli A, Trachana M, Farmaki E, Tzimouli V, Pratsidou-Gertsi P, Printza N, Garyphallos A, Galanopoulou V, Kanakoudi-Tsakalidou F, Papachristou F. Clin Exp Immunol; 2017 Apr; 188(1):79-85. PubMed ID: 27936517 [Abstract] [Full Text] [Related]
2. Diagnostic value of serum high-mobility group box-1 in pediatric systemic lupus erythematosus. Hossny E, El-Ghoneimy D, Soliman DA, Ashour A. Int J Rheum Dis; 2019 Aug; 22(8):1402-1409. PubMed ID: 30938057 [Abstract] [Full Text] [Related]
3. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus. Picard C, Lega JC, Ranchin B, Cochat P, Cabrera N, Fabien N, Belot A. Pediatr Nephrol; 2017 Sep; 32(9):1537-1545. PubMed ID: 28343355 [Abstract] [Full Text] [Related]
4. Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus. Haddon DJ, Diep VK, Price JV, Limb C, Utz PJ, Balboni I. Arthritis Res Ther; 2015 Jun 17; 17(1):162. PubMed ID: 26081107 [Abstract] [Full Text] [Related]
5. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus. Orjuela A, Suwanichkul A, Canter D, Minard CG, Devaraj S, Hicks MJ, Muscal E, Wenderfer SE. Am J Nephrol; 2015 Jun 17; 41(3):241-7. PubMed ID: 25926050 [Abstract] [Full Text] [Related]
6. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G. Clin Rheumatol; 2003 Oct 17; 22(4-5):271-8. PubMed ID: 14576989 [Abstract] [Full Text] [Related]
7. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity. Emad G, Al-Barshomy SM. Saudi J Kidney Dis Transpl; 2020 Oct 17; 31(2):342-352. PubMed ID: 32394906 [Abstract] [Full Text] [Related]
8. High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Abdulahad DA, Westra J, Bijzet J, Limburg PC, Kallenberg CG, Bijl M. Arthritis Res Ther; 2011 May 06; 13(3):R71. PubMed ID: 21548924 [Abstract] [Full Text] [Related]
9. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M. Ann N Y Acad Sci; 2005 Jun 06; 1050():193-200. PubMed ID: 16014534 [Abstract] [Full Text] [Related]
10. Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE. New therapeutic options? Kanakoudi-Tsakalidou F, Farmaki E, Tzimouli V, Taparkou A, Paterakis G, Trachana M, Pratsidou-Gertsi P, Nalbanti P, Papachristou F. Lupus; 2014 Mar 06; 23(3):305-12. PubMed ID: 24399813 [Abstract] [Full Text] [Related]
11. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis]. Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ. Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738 [Abstract] [Full Text] [Related]
12. Serum A08 C1q antibodies are associated with disease activity and prognosis in Chinese patients with lupus nephritis. Pang Y, Tan Y, Li Y, Zhang J, Guo Y, Guo Z, Zhang C, Yu F, Zhao MH. Kidney Int; 2016 Dec 02; 90(6):1357-1367. PubMed ID: 27745701 [Abstract] [Full Text] [Related]
13. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA. Ann Rheum Dis; 2005 Mar 02; 64(3):444-8. PubMed ID: 15286009 [Abstract] [Full Text] [Related]
14. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis. Chen PC, Wang CR, Liu MF, Chen FF, Liang CC. Asian Pac J Allergy Immunol; 2002 Dec 02; 20(4):223-7. PubMed ID: 12744622 [Abstract] [Full Text] [Related]
15. Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus. Zhang CX, Cai L, Shao K, Wu J, Zhou W, Cao LF, Chen TX. Pediatr Nephrol; 2018 May 02; 33(5):837-845. PubMed ID: 29264699 [Abstract] [Full Text] [Related]
16. Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis. Tan Y, Song D, Wu LH, Yu F, Zhao MH. BMC Nephrol; 2013 Mar 19; 14():63. PubMed ID: 23510032 [Abstract] [Full Text] [Related]
17. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus. Seelen MA, Trouw LA, Daha MR. Curr Opin Nephrol Hypertens; 2003 Nov 19; 12(6):619-24. PubMed ID: 14564199 [Abstract] [Full Text] [Related]
18. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus. Gargiulo Mde L, Gómez G, Khoury M, Collado MV, Suárez L, Álvarez C, Sarano J. Medicina (B Aires); 2015 Nov 19; 75(1):23-8. PubMed ID: 25637896 [Abstract] [Full Text] [Related]
19. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis. Elshweikh SA, Elkhouly RM, Shaalan MM, Shorbagy SH. Egypt J Immunol; 2014 Nov 19; 21(2):49-59. PubMed ID: 25812352 [Abstract] [Full Text] [Related]
20. Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China. Zhang CQ, Ren L, Gao F, Mu FY, You YQ, Liu YH. Clin Rheumatol; 2011 Jul 19; 30(7):967-73. PubMed ID: 21340499 [Abstract] [Full Text] [Related] Page: [Next] [New Search]